Back

Elegibility for sacubitril/valsartan utilization in acute heart failure

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Acute Heart Failure– Treatment Treatment HFA Premium Access Heart Failure 2018

About the speaker

Photo
Associate Professor Luiz Carlos Passos

Federal University of Bahia, Salvador (Brazil)

11 More presentations in this session

Presentation thumbnail
Digoxin and Prognosis of Heart Failure in Older Patients with Preserved Ejection Fraction: Importance of Heart Rate
Doctor P. Llacer (Madrid, ES)
Abstract
Presentation thumbnail
Efficacy of Tolvaptan for the first hospitalized patients with acute decompensated heart failure
Doctor Y. Suzuki (Nagakute-cho, JP)
Abstract Slides
Presentation thumbnail
Safety and efficacy of tolvaptan administration in patients hospitalised for acute decompensated heart failure due to moderate or severe aortic stenosis
Doctor R. Hata (Kurashiki, JP)
Abstract Slides
Presentation thumbnail
Effects of low dose levosimendan on renal function in patients with advanced heart failure
Doctor R. Dierckx (Aalst, BE)
Abstract
Presentation thumbnail
Using Levosimanden in place for unresponsive acute decompensated heart failure to dobutamine
Doctor M. Chou (Tainan, TW)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Acute Heart Failure– Treatment

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Early hospital management
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Presentation
Acute and advanced heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources